Results 241 to 250 of about 371,184 (271)
Some of the next articles are maybe not open access.
Building a better sphingosine kinase-1 inhibitor
Biochemical Journal, 2012Sphingosine 1-phosphate (S1P) is currently one of the most intensely studied lipid mediators. Interest in S1P has been propelled by the development of fingolimod, an S1P receptor agonist prodrug, which revealed both a theretofore unsuspected role of S1P in lymphocyte trafficking and that such modulation of the immune system achieves therapeutic benefit
openaire +2 more sources
Downregulating sphingosine kinase-1 for cancer therapy
Expert Opinion on Therapeutic Targets, 2008The sphingolipids ceramide and sphingosine 1-phosphate (S1P) are key regulators of cell death and proliferation. The subtle balance between their intracellular levels is governed mainly by sphingosine kinase-1, which produces the pro-survival S1P. Sphingosine kinase-1 is an oncogene; is overexpressed in many tumors; protects cancer cells from apoptosis
openaire +2 more sources
[Sphingosine kinase 1 and tumor].
Yao xue xue bao = Acta pharmaceutica Sinica, 2016Sphingolipids as an important regulator play a critical role in the cell biological functions. Among them, ceramide (Cer) and sphingosine (Sph) induce apoptosis and inhibit cell proliferation; on the contrary sphingosine 1-phosphate (S1P) promotes cell survival and proliferation.
Cai-Xia, Zhang +2 more
openaire +1 more source
Functional implications of pH-induced conformational changes in the Sphingosine kinase 1.
Spectrochimica Acta Part A - Molecular and Biomolecular Spectroscopy, 2020Preeti Gupta +9 more
semanticscholar +1 more source
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease
Nature Reviews Gastroenterology and Hepatology, 2022Bram Verstockt +2 more
exaly
European Review for Medical and Pharmacological Sciences, 2018
Lei Liu +8 more
semanticscholar +1 more source
Lei Liu +8 more
semanticscholar +1 more source
Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases
Nature Reviews Rheumatology, 2022Nathalie Burg, Timothy T Hla
exaly

